These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36824732)

  • 1. Low Gut Microbial Diversity Augments Estrogen-driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease.
    Chioma OS; Mallott E; Shah-Gandhi B; Wiggins Z; Langford M; Lancaster AW; Gelbard A; Wu H; Johnson JE; Lancaster L; Wilfong EM; Crofford LJ; Montgomery CG; Van Kaer L; Bordenstein S; Newcomb DC; Drake WP
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Gut Microbial Diversity Augments Estrogen-Driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease.
    Chioma OS; Mallott E; Shah-Gandhi B; Wiggins Z; Langford M; Lancaster AW; Gelbard A; Wu H; Johnson JE; Lancaster L; Wilfong EM; Crofford LJ; Montgomery CG; Van Kaer L; Bordenstein S; Newcomb DC; Drake WP
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 up-regulation on CD4
    Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
    Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
    J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
    Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.
    Segawa S; Goto D; Iizuka A; Kaneko S; Yokosawa M; Kondo Y; Matsumoto I; Sumida T
    Clin Exp Immunol; 2016 Sep; 185(3):348-60. PubMed ID: 27083148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota modulates lung fibrosis severity following acute lung injury in mice.
    Chioma OS; Mallott EK; Chapman A; Van Amburg JC; Wu H; Shah-Gandhi B; Dey N; Kirkland ME; Blanca Piazuelo M; Johnson J; Bernard GR; Bodduluri SR; Davison S; Haribabu B; Bordenstein SR; Drake WP
    Commun Biol; 2022 Dec; 5(1):1401. PubMed ID: 36543914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.
    Reilkoff RA; Peng H; Murray LA; Peng X; Russell T; Montgomery R; Feghali-Bostwick C; Shaw A; Homer RJ; Gulati M; Mathur A; Elias JA; Herzog EL
    Am J Respir Crit Care Med; 2013 Jan; 187(2):180-8. PubMed ID: 23220917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive Senescence and Ischemic Stroke Remodel the Gut Microbiome and Modulate the Effects of Estrogen Treatment in Female Rats.
    Park MJ; Pilla R; Panta A; Pandey S; Sarawichitr B; Suchodolski J; Sohrabji F
    Transl Stroke Res; 2020 Aug; 11(4):812-830. PubMed ID: 31845185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of all-trans retinoic acid in bleomycin-induced pulmonary fibrosis in mice.
    Dong Z; Tai W; Yang Y; Zhang T; Li Y; Chai Y; Zhong H; Zou H; Wang D
    Exp Lung Res; 2012 Mar; 38(2):82-9. PubMed ID: 22250783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
    Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R
    FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis.
    Singh B; Kasam RK; Sontake V; Wynn TA; Madala SK
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L796-L806. PubMed ID: 28775096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoregulatory role of IL-35 in patients with interstitial lung disease.
    Osuna-Gómez R; Barril S; Mulet M; Zamora Atenza C; Millan-Billi P; Pardessus A; Brough DE; Sabzevari H; Semnani RT; Castillo D; Vidal S
    Immunology; 2023 Apr; 168(4):610-621. PubMed ID: 36273280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice.
    Qu Z; Dou W; Zhang K; Duan L; Zhou D; Yin S
    Arthritis Res Ther; 2022 Dec; 24(1):280. PubMed ID: 36564791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis.
    Gasse P; Riteau N; Vacher R; Michel ML; Fautrel A; di Padova F; Fick L; Charron S; Lagente V; Eberl G; Le Bert M; Quesniaux VF; Huaux F; Leite-de-Moraes M; Ryffel B; Couillin I
    PLoS One; 2011; 6(8):e23185. PubMed ID: 21858022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qi-Long-Tian capsule alleviates pulmonary fibrosis development by modulating inflammatory response and gut microbiota.
    Zhang Q; Luo T; Yuan D; Liu J; Fu Y; Yuan J
    Funct Integr Genomics; 2023 Feb; 23(1):64. PubMed ID: 36810971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.